Monkeypox: EU approves vaccine to combat outbreak | World News,The Indian Express

The vaccine by Danish biotech company Bavarian Nordic has already been approved for the prevention of monkeypox in the US and Canada. The decision comes a day after the WHO declared the disease a global health emergency.

The European Commission approved Bavarian Nordic’s Imvanex vaccine — which protects against smallpox — for use against monkeypox in the EU, the Danish biotech company said on Monday.

Bavarian Nordic said the approval came after “a positive opinion” from the Committee for Medicinal Products for Human Use (CHMP) last week, and is valid in all EU member states.

“The availability of an approved vaccine can significantly improve nations’ readiness to fight emerging diseases, but only through investments and structured planning of the biological preparedness,” Bavarian Nordic’s Chief Executive Paul Chaplin said.

The announcement comes a day after the World Health Organization (WHO) declared the monkeypox outbreak a global health emergency.

Chaplin told Reuters news agency that the company was also in talks to potentially grow production capacity and could meet demand for the monkeypox vaccine in the tens of millions.

https://indianexpress.com/article/world/monkeypox-eu-approves-vaccine-to-combat-outbreak-8051951/

---